Tetragraph Neuromuscular Transmission Monitor— 510(k) K220530

Substantially Equivalent

Senzime AB

FDA 510(k) clearance K220530 for Tetragraph Neuromuscular Transmission Monitor, Substantially Equivalent on 2022-08-17. Applicant: Senzime AB.

Clearance details

Applicant: Senzime AB
Product code: Code KOI
Advisory panel: Anesthesiology
Date received: 2022-02-24
Decision date: 2022-08-17
Decision: Substantially Equivalent
Clearance type: Traditional
Location: Uppsala, SE

Download summary PDF View on FDA.gov ↗

Data sourced from openFDA. This site is unofficial and independent of the FDA.